-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on CVS Health, Raises Price Target to $101

Benzinga·12/17/2025 19:20:25
Listen to the news
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $93 to $101.